36 results on '"Champlin, R. E."'
Search Results
2. Autologous stem cell transplantation (ASCT) as upfront or salvage therapy for noncutaneous T-cell lymphoma (TCL): The University of Texas M. D. Anderson Cancer Center (MDACC) experience.
3. Bendamustine in combination with fludarabine and rituximab: A novel nonmyeloablative conditioning for allogeneic stem cell transplantation (AST) in patients with lymphoid malignancies.
4. Phase II study of gonadotropin-releasing hormone analogue for ovarian function preservation in hematopoietic stem cell transplantation patients.
5. Long-term outcome after hyper-CVAD and imatinib (IM) for de novo or minimally treated Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-ALL).
6. Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
7. Treatment of acute myeloid leukemia (AML) in first remission (CR1) with unrelated donor (UD) allogeneic hematopoietic cell transplantation (HCT).
8. Hyperglycemia in stem cell transplant recipients: A modifiable risk factor for infection
9. Outcome after frontline therapy with the hyper-CVAD and imatinib mesylate regimen for adults with de novo or minimally treated Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL)
10. A pilot study CD34 selected haploidentical transplant using a chemotherapy-only preparative regimen and intensive antibiotic prophylaxis for treatment of advanced leukemia
11. Outcome of allogenic SCT in patients with low left ventricular ejection fraction
12. PR1 peptide vaccination for patients with myeloid leukemias
13. Treatment of patients (pts) with chronic myeloid leukemia (CML) and imatinib failure after developing BCR-ABL kinase mutations with allogeneic stem cell transplantation (ASCT)
14. Allogeneic hematopoietic stem cell transplantation for cutaneous T-cell lymphoma (CTCL)
15. Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic stem cell transplantation (ASCT) in patients (pts) with chronic myeloid leukemia (CML): No evidence for increased transplant-related toxicity
16. The influence of PET/Gallium (P/G) status and high-dose rituximab (HDR) in patients (pts) with aggressive, large, B-cell lymphoma (LBCL) receiving autologous stem cell transplants (ASCT)
17. Twelve-year follow-up of a randomized trial of high-dose chemotherapy (HDC) and autologous hematopoietic stem cell support (ASCS) for high-risk primary breast carcinoma
18. Trastuzumab plus GM-CSF for patients with trastuzumab-resistant, HER2-overexpressing metastatic breast cancer: Pilot study
19. Sirolimus in combination with tacrolimus for the treatment of resistant chronic graft-versus-host disease
20. Accurate response assessment of breast cancer bone metastasis using computed tomography and new response criteria
21. The efficacy of non-myeloablative allogeneic stem cell transplantation in ZAP-70 positive/chemo-antibody refractory patients with chronic lymphocytic leukemia (CLL)
22. Complete response of bone-only metastatic breast cancer to skeletal: Targeted radiotherapy with 166HOLMIUM-DOTMP
23. Mesenchymal stem cells as delivery systems for cancer and leukemia gene therapy
24. Interleukin-2 (IL-2) with high-dose chemotherapy (HDC) and autologous hematopoietic stem-cell transplantation (AHST) for poor-risk metastatic breast cancer (MBC)
25. Use of intensive antibiotic prophylaxis and a chemotherapy only T-cell depleted preparative regimen (prep reg) as a pilot study in haploidentical (haplo) transplant (tp) for treatment of pts with advanced leukemia
26. Interleukin-2 (IL-2) with high-dose chemotherapy (HDC) and autologous hematopoietic stem-cell transplantation (AHST) for poor-risk metastatic breast cancer (MBC)
27. Mesenchymal stem cells as delivery systems for cancer and leukemia gene therapy
28. Use of intensive antibiotic prophylaxis and a chemotherapy only T-cell depleted preparative regimen (prep reg) as a pilot study in haploidentical (haplo) transplant (tp) for treatment of pts with advanced leukemia
29. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
30. Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
31. Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer.
32. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
33. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.
34. Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.
35. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.
36. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.